Genetic structure could hold some answers to the vexed issue of cancer. A reference set of genetic variants, specific to India’s diverse ethnic groups, can improve disease modelling and treatment.
Related Posts
Mankind Pharma IPO: Mankind Pharma IPO: Reasonably priced, investors may join the company on its ‘Bharat-to-India’ quest
Rajeev Juneja, Vice Chairman & Managing Director at Mankind Pharma Ltd. image courtesy: company. Synopsis Adopting a contrarian strategy, Mankind…
A new lease of life: How India’s first CAR-T cell therapy is helping patients battle cancer.
The ImmunoACT team that worked on India’s first approved CAR-T therapy NexCAR 19; image courtesy: ImmunoACT Synopsis NexCAR 19, India’s…
PharmEasy has skipped the growth pill for profitability. This may lead to side effects
Healthtech company PharmEasy seems to finally be able to hold its head above water. The unicorn, which has been struggling…
